Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-132-5p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 123, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
SERPINA1 hsa-miR-132-5p low: 9 high: 0 1 3 3 -
Low-throughput experiments (3 positive, 6 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Hassan Tidi et al. 2013 qP O Peripheral Blood THP1 N/A Normal
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR NEGATIVE INDIRECT TarBase 7.0
UNKNOWN ELISA NEGATIVE INDIRECT TarBase 7.0
Hassan Tidi et al. 2013 qP O Liver HEPG2 N/A Normal
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR NEGATIVE INDIRECT TarBase 7.0
UNKNOWN ELISA NEGATIVE INDIRECT TarBase 7.0
Hassan Tidi et al. 2013 qP O Bronchus 16HBE14O N/A Normal
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR NEGATIVE INDIRECT TarBase 7.0
UNKNOWN ELISA NEGATIVE INDIRECT TarBase 7.0
Hassan Tidi et al. 2013 RP Peripheral Blood THP1 HEK293 Normal
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
Hassan Tidi et al. 2013 RP Liver HEPG2 HEK293 Normal
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
Hassan Tidi et al. 2013 RP Bronchus 16HBE14O HEK293 Normal
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
ZNF771 hsa-miR-132-5p low: 0 high: 11 1 1 1 -
High-throughput experiments (11 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30407586-30407598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MSL1 hsa-miR-132-5p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:40135602-40135629 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr17:40135602-40135629 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:40129403-40129426 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ANAPC7 hsa-miR-132-5p low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:110374266-110374289 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:110374266-110374289 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr12:110377503-110377512 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HIPK2 hsa-miR-132-5p low: 0 high: 2 1 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:139596780-139596800 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr7:139596780-139596800 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EIF3B hsa-miR-132-5p low: 0 high: 2 1 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:2369522-2369546 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr7:2380541-2380563 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PCYOX1 hsa-miR-132-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:70277521-70277544 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:70277154-70277173 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MORF4L2 hsa-miR-132-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chrX:103675572-103675600 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chrX:103675572-103675600 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UNC45A hsa-miR-132-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr15:90952990-90953014 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr15:90940446-90940473 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RGMB hsa-miR-132-5p low: 0 high: 2 2 2 2 0.556
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:98794172-98794186 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:98794172-98794186 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SPRTN hsa-miR-132-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:231354810-231354834 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NCAPD2 hsa-miR-132-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:6516840-6516864 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PIK3C2A hsa-miR-132-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:17087656-17087679 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ARNTL2 hsa-miR-132-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr12:27333030-27333042 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SNX29 hsa-miR-132-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr16:12569943-12569969 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FNIP2 hsa-miR-132-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr4:158905190-158905210 HITS-CLIP POSITIVE DIRECT TarBase 7.0
U2AF2 hsa-miR-132-5p low: 0 high: 1 1 1 1 0.456
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:55674427-55674434 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SBNO2 hsa-miR-132-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:1122494-1122512 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SPEN hsa-miR-132-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:15935807-15935819 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PFN2 hsa-miR-132-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:149966228-149966250 HITS-CLIP POSITIVE DIRECT TarBase 7.0